|
CCDC82 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.335600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.269600E-02 |
| Normal-vs-Stage2 |
2.354400E-01 |
| Normal-vs-Stage3 |
2.316400E-01 |
| Normal-vs-Stage4 |
1.515180E-01 |
| Stage1-vs-Stage2 |
8.081800E-01 |
| Stage1-vs-Stage3 |
6.764800E-03 |
| Stage1-vs-Stage4 |
8.977600E-02 |
| Stage2-vs-Stage3 |
7.695900E-02 |
| Stage2-vs-Stage4 |
1.156650E-01 |
| Stage3-vs-Stage4 |
7.293800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.914000E-02 |
| Normal-vs-AfricanAmerican |
2.724400E-01 |
| Normal-vs-Asian |
9.822200E-01 |
| Caucasian-vs-AfricanAmerican |
7.850200E-01 |
| Caucasian-vs-Asian |
5.806600E-01 |
| AfricanAmerican-vs-Asian |
6.746600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.327830E-01 |
| Normal-vs-Female |
1.778480E-02 |
| Male-vs-Female |
1.350800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.592200E-01 |
| Normal-vs-Extreme_Weight |
3.640400E-01 |
| Normal-vs-Obese |
9.555800E-02 |
| Normal-vs-Extreme_Obese |
9.177800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.822600E-01 |
| Normal_Weight-vs-Obese |
5.072800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.787400E-01 |
| Extreme_Weight-vs-Obese |
4.690000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.683400E-01 |
| Obese-vs-Extreme_Obese |
4.891800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.120150E-01 |
| Normal-vs-Age(41-60Yrs) |
2.516300E-03 |
| Normal-vs-Age(61-80Yrs) |
5.072600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.121800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.109400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.414000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.056200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.643700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.102100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.930000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.185000E-04 |
| Normal-VS-Type2 PRCC |
1.149440E-01 |
| Normal-VS-KIRP CIMP |
6.088200E-01 |
| Normal-VS-Unclassified PRCC |
1.319960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.02269999996607E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.024250E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.144600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.949600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.731630E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.652800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.555400E-01 |
| Normal-vs-N1 |
1.023820E-01 |
| Normal-vs-N2 |
1.568580E-01 |
| N0-vs-N1 |
2.544400E-01 |
| N0-vs-N2 |
3.654800E-01 |
| N1-vs-N2 |
6.122000E-01 |
|
|
